Bagi Zsolt

1.

Kolijn, D., Pabel, S., Tian, Y., Lódi, M., Herwig, M., Carrizzo, A., Zhazykbayeva, S., Kovács, Á., Fülöp, G. Á., Falcao-Pires, I., Reusch, P. H., Linthout, S. V., Papp, Z., Heerebeek, L. v., Vecchione, C., Maier, L. S., Ciccarelli, M., Tschöpe, C., Mügge, A., Bagi, Z., Sossalla, S., Hamdani, N.: Empagliflozin Improves Endothelial and Cardiomyocyte Function in Human Heart Failure With Preserved Ejection Fraction via Reduced Pro-Inflammatory-Oxidative Pathways and Protein Kinase Gα Oxidation.
Cardiovasc. Res. 117 (2), 495-507, 2021.

doi DEA WoS Scopus

Journal metrics:

D1 Cardiology and Cardiovascular Medicine

D1 Physiology

D1 Physiology (medical)

2.

Gődény, I., Pollesello, P., Édes, I., Papp, Z., Bagi, Z.: Levosimendan and its metabolite OR-1896 elicit KATP channel-dependent dilation in resistance arteries in vivo.
Pharmacol Rep. 65, 1304-1310, 2013.

DEA

Journal metrics:

Q2 Medicine (miscellaneous)

Q2 Pharmacology

3.

Beleznai, T., Bagi, Z.: Activation of hexosamine pathway impairs nitric oxide (NO)-dependent arteriolar dilations by increased protein O-GlcNAcylation.
Vasc. Pharmacol. 56 (3-4), 115-121, 2012.

doi DEA

Journal metrics:

Q2 Molecular Medicine

Q1 Pharmacology

Q2 Physiology

4.

Bagi, Z., Fehér, A., Cassuto, J.: Microvascular responsiveness in obesity: implications for therapeutic intervention.
Br. J. Pharmacol. 165 (3), 544-560, 2012.

doi DEA

Journal metrics:

D1 Pharmacology

5.

Beleznai, T., Fehér, A., Spielvogel, D., Lansman, S. L., Bagi, Z.: Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes.
Am. J. Physiol.-Heart Circul. Physiol. 300 (3), H777-H783, 2011.

doi DEA

Journal metrics:

Q1 Cardiology and Cardiovascular Medicine

Q1 Physiology

Q1 Physiology (medical)

6.

Bagi, Z., Fehér, A., Cassuto, J., Akula, K., Labinskyy, N., Kaley, G., Koller, Á.: Increased availability of angiotensin AT1 receptors leads to sustained arterial constriction to angiotensin II in diabetes - role for Rho-kinase activation.
Br. J. Pharmacol. 163 (5), 1059-1068, 2011.

doi DEA

Journal metrics:

D1 Pharmacology

7.

Fehér, A., Rutkai, I., Beleznai, T., Ungvári, Z., Csiszár, A., Édes, I., Bagi, Z.: Caveolin-1 limits the contribution of BK(Ca) channel to EDHF-mediated arteriolar dilation: implications in diet-induced obesity.
Cardiovasc. Res. 87 (4), 732-739, 2010.

doi DEA

Journal metrics:

D1 Cardiology and Cardiovascular Medicine

D1 Physiology

D1 Physiology (medical)

8.

Ungvári, Z., Bagi, Z., Fehér, A., Recchia, F. A., Sonntag, W. E., Pearson, K., de Cabo, R., Csiszár, A.: Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2.
Am. J. Physiol. Heart Circ. Physiol. 299 (1), H18-H24, 2010.

doi DEA

Journal metrics:

Q1 Cardiology and Cardiovascular Medicine

Q1 Physiology

Q1 Physiology (medical)

9.

Rutkai, I., Fehér, A., Erdei, N., Henrion, D., Papp, Z., Édes, I., Koller, Á., Kaley, G., Bagi, Z.: Activation of prostaglandin E2 EP1 receptor increases arteriolar tone and blood pressure in mice with type 2 diabetes.
Cardiovasc. Res. 83 (1), 148-154, 2009.

doi DEA

Journal metrics:

D1 Cardiology and Cardiovascular Medicine

D1 Physiology

D1 Physiology (medical)

10.

Bagi, Z., Fehér, A., Beleznai, T.: Preserved coronary arteriolar dilatation in patients with type 2 diabetes mellitus: Implications for reactive oxygen species.
Pharmacol. Rep. 61 (1), 99-104, 2009.

DEA

Journal metrics:

Q1 Medicine (miscellaneous)

Q2 Pharmacology

11.

Rácz, A., Veresh, Z., Erdei, N., Bagi, Z., Koller, Á.: Thromboxane A2 Contributes to the Mediation of Flow-Induced Responses of Skeletal Muscle Venules: role of Cyclooxygenases 1 and 2.
J. Vasc. Res. 46 (5), 397-405, 2009.

doi DEA

Journal metrics:

Q2 Cardiology and Cardiovascular Medicine

Q2 Physiology

12.

Jebelovszki, É., Király, C., Erdei, N., Fehér, A., Pásztorné Tóth, E., Rutkai, I., Forster, T., Édes, I., Koller, Á., Bagi, Z.: High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation.
Am. J. Physiol. Heart Circ. Physiol. 294 (6), H2558-H2564, 2008.

doi DEA

Journal metrics:

D1 Cardiology and Cardiovascular Medicine

Q1 Physiology

Q1 Physiology (medical)

13.

Bagi, Z., Erdei, N., Koller, Á.: High intraluminal pressure via H2O2 upregulates arteriolar constrictions to angiotensin II by increasing the functional availability of AT1 receptors.
Am. J. Physiol. Heart Circ. Physiol. 295 (2), H835-H841, 2008.

doi DEA

Journal metrics:

D1 Cardiology and Cardiovascular Medicine

Q1 Physiology

Q1 Physiology (medical)

14.

Kark, T., Bagi, Z., Lizanecz, E., Pásztorné Tóth, E., Erdei, N., Czikora, Á., Papp, Z., Édes, I., Pórszász, R., Tóth, A.: Tissue-specific regulation of microvascular diameter: opposite functional roles of neuronal and smooth muscle located vanilloid receptor-1.
Mol. Pharmacol. 73 (5), 1405-1412, 2008.

doi DEA

Journal metrics:

D1 Molecular Medicine

D1 Pharmacology

15.

Fülöp, T., Jebelovszki, É., Erdei, N., Szerafin, T., Forster, T., Édes, I., Koller, Á., Bagi, Z.: Adaptation of Vasomotor Function of Human Coronary Arterioles to the Simultaneous Presence of Obesity and Hypertension.
Arterioscler. Thromb. Vasc. Biol. 27 (11), 2348-2354, 2007.

doi DEA

Journal metrics:

D1 Cardiology and Cardiovascular Medicine

16.

Tóth, J., Rácz, A., Kaminski, P. M., Wolin, M. S., Koller, Á., Bagi, Z.: Asymmetrical dimethylarginine inhibits shear stress-induced nitric oxide release and dilation and elicits superoxide-mediated increase in arteriolar tone.
Hypertension. 49 (3), 563-568, 2007.

doi DEA

Journal metrics:

D1 Internal Medicine

17.

Tóth, E., Rácz, A., Tóth, J., Kaminski, P. M., Wolin, M. S., Koller, Á., Bagi, Z.: Contribution of polyol pathway to arteriolar dysfunction in hyperglycemia: role of oxidative stress, reduced NO, and enhanced PGH(2)/TXA(2) mediation.
Am. J. Physiol. Heart Circ. Physiol. 293 (5), H3096-H3104, 2007.

doi DEA

Journal metrics:

D1 Cardiology and Cardiovascular Medicine

Q1 Physiology

Q1 Physiology (medical)

18.

Erdei, N., Édes, I., Kaley, G., Koller, Á., Bagi, Z.: H2O2 increases production of constrictor prostaglandins in smooth muscle leading to enhanced arteriolar tone in Type 2 diabetic mice.
Am. J. Physiol. Heart Circ. Physiol. 292 (1), H649-H656, 2007.

doi DEA

Journal metrics:

D1 Cardiology and Cardiovascular Medicine

Q1 Physiology

Q1 Physiology (medical)

19.

Molnár, A., Tóth, A., Bagi, Z., Papp, Z., Édes, I., Vaszily, M., Galajda, Z., Papp, G. J., Varró, A., Szűts, V., Lacza, Z., Gerö, D., Szabó, C.: Activation of the Poly(ADP-Ribose) Polymerase Pathway in Human Heart Failure.
Mol. Med. 12 (7-8), 143-152, 2006.

doi DEA

Journal metrics:

Q2 Genetics

Q2 Genetics (clinical)

Q2 Molecular Biology

Q1 Molecular Medicine

20.

Erdei, N., Tóth, A., Pásztorné Tóth, E., Papp, Z., Édes, I., Koller, Á., Bagi, Z.: High-fat diet-induced reduction in nitric oxide-dependent arteriolar dilation in rats: role of xanthine oxidase-derived superoxide anion.
Am. J. Physiol.-Heart Circul. Physiol. 291 (5), H2107-H2115, 2006.

doi DEA

Journal metrics:

D1 Cardiology and Cardiovascular Medicine

Q1 Physiology

Q1 Physiology (medical)

21.

Szerafin, T., Erdei, N., Fülöp, T., Pásztorné Tóth, E., Édes, I., Koller, Á., Bagi, Z.: Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus.
Circ. Res. 99 (5), e12-e17, 2006.

doi DEA

Journal metrics:

D1 Cardiology and Cardiovascular Medicine

D1 Physiology

22.

Bagi, Z., Hamar, P., Kardos, M., Koller, Á.: Lack of flow mediated dilation and enhanced angiotensin II-induced constriction in skeletal muscle arterioles of lupus-prone autoimmune mice.
Lupus. 15 (6), 326-334, 2006.

doi DEA

Journal metrics:

Q1 Rheumatology

23.

Lizanecz, E., Bagi, Z., Pásztorné Tóth, E., Papp, Z., Édes, I., Kedei, N., Blumberg, P. M., Tóth, A.: Phosphorylation-Dependent Desensitization by Anandamide of Vanilloid Receptor-1 (TRPV1) Function in Rat Skeletal Muscle Arterioles and in Chinese Hamster Ovary Cells Expressing TRPV1.
Mol. Pharmacol. 69 (3), 1015-1023, 2006.

doi DEA

Journal metrics:

D1 Molecular Medicine

D1 Pharmacology

24.

Erdei, N., Papp, Z., Pollesello, P., Édes, I., Bagi, Z.: The levosimendan metabolite OR-1896 elicits vasodilation by activating the KATP and BKCa channels in rat isolated arterioles.
Br. J. Pharmacol. 148 (5), 696-702, 2006.

doi DEA

Journal metrics:

Q1 Pharmacology

25.

Bagi, Z., Erdei, N., Papp, Z., Édes, I., Koller, Á.: Up-regulation of vascular cyclooxygenase-2 in diabetes mellitus.
Pharmacol. rep. 58, 52-56, 2006.

DEA

Journal metrics:

Q2 Medicine (miscellaneous)

Q3 Pharmacology

Publication list